XIAOMI-W
01810
TENCENT
00700
BEKE-W
02423
BOSS ZHIPIN-W
02076
BABA-W
09988
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -71.09%-92.14M | ---- | -0.64%-53.85M | ---- | -36.71%-53.51M | ---- | 66.51%-39.14M | ---- | 19.09%-116.89M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -53.96%-29.88M | ---- | 24.82%-19.4M | ---- | 1.44%-25.81M | ---- | 7.01%-26.19M | ---- | -8.34%-28.16M |
Interest expense - adjustment | ---- | 56.04%12.37M | ---- | 6.42%7.93M | ---- | -32.81%7.45M | ---- | 66.81%11.08M | ---- | 1.65%6.64M |
Dividend (income)- adjustment | ---- | 87.45%-850K | ---- | -456.53%-6.77M | ---- | -396.73%-1.22M | ---- | 68.26%-245K | ---- | 80.14%-772K |
Impairment and provisions: | ---- | 517.35%42.91M | ---- | 267.34%6.95M | ---- | 30.75%1.89M | ---- | -91.38%1.45M | ---- | 168.84%16.79M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M |
-Other impairments and provisions | ---- | 517.35%42.91M | ---- | 267.34%6.95M | ---- | 30.75%1.89M | ---- | 145.06%1.45M | ---- | -151.42%-3.21M |
Revaluation surplus: | ---- | 106.71%2.04M | ---- | -302.03%-30.45M | ---- | 353.19%15.07M | ---- | -64.08%3.33M | ---- | -33.49%9.26M |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.59%-824K | ---- | -476.27%-444K |
-Other fair value changes | ---- | 106.71%2.04M | ---- | -302.03%-30.45M | ---- | 263.20%15.07M | ---- | -57.23%4.15M | ---- | -29.71%9.7M |
Asset sale loss (gain): | ---- | 90.91%21K | ---- | 100.89%11K | ---- | ---1.24M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 90.91%21K | ---- | -96.60%11K | ---- | --324K | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---1.56M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 1.24%13.26M | ---- | 51.42%13.1M | ---- | -1.36%8.65M | ---- | -62.93%8.77M | ---- | 496.12%23.65M |
-Depreciation | ---- | 1.24%13.26M | ---- | 51.42%13.1M | ---- | -1.36%8.65M | ---- | -62.93%8.77M | ---- | 496.12%23.65M |
Special items | ---- | -1,026.98%-584K | ---- | -89.76%63K | ---- | -86.81%615K | ---- | 14,475.00%4.66M | ---- | 39.13%32K |
Operating profit before the change of operating capital | ---- | 35.89%-52.85M | ---- | -71.38%-82.44M | ---- | -32.56%-48.1M | ---- | 59.43%-36.29M | ---- | 37.74%-89.45M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 218.55%16.37M | ---- | -110.92%-13.81M | ---- | 14,888.65%126.44M | ---- | 96.92%-855K | ---- | -126.59%-27.78M |
Accounts payable increase (decrease) | ---- | 19.63%-142.76M | ---- | -15.48%-177.62M | ---- | -337.69%-153.81M | ---- | 132.75%64.71M | ---- | -1,771.57%-197.61M |
prepayments (increase)decrease | ---- | 114.49%7.04M | ---- | -4,937.20%-48.61M | ---- | -171.59%-965K | ---- | -85.14%1.35M | ---- | 447.64%9.07M |
Financial assets at fair value (increase)decrease | ---- | -104.54%-4.79M | ---- | 427.90%105.44M | ---- | -315.83%-32.16M | ---- | -53.64%14.9M | ---- | -17.47%32.14M |
Special items for working capital changes | ---- | -32.38%143.54M | ---- | 213.11%212.27M | ---- | 184.68%67.8M | ---- | -148.32%-80.06M | ---- | 113.54%165.67M |
Cash from business operations | ---- | -603.70%-33.43M | ---- | 88.35%-4.75M | ---- | -12.56%-40.79M | ---- | 66.43%-36.24M | ---- | -224.74%-107.97M |
Dividend received - operating | ---- | -87.45%850K | ---- | 456.53%6.77M | ---- | 396.73%1.22M | ---- | -68.26%245K | ---- | -80.14%772K |
Interest received - operating | ---- | 54.35%29.77M | ---- | -24.96%19.29M | ---- | -2.33%25.7M | ---- | -6.02%26.31M | ---- | 0.93%28M |
Special items of business | 122.55%9.97M | ---- | -137.68%-44.19M | ---- | 116.29%117.27M | ---- | -1,345.91%-719.77M | ---- | 76.33%-49.78M | ---- |
Net cash from operations | 122.55%9.97M | -113.22%-2.82M | -137.68%-44.19M | 253.53%21.31M | 116.29%117.27M | -43.29%-13.88M | -1,345.91%-719.77M | 87.77%-9.69M | 76.33%-49.78M | -167.02%-79.2M |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | ---- | ---- | 194.41%1M | ---- | 125.35%340K | ---- | ---1.34M | ---- | ---- |
Purchase of fixed assets | ---- | 92.66%-124K | ---- | 61.94%-1.69M | ---- | -151.02%-4.44M | ---- | 82.03%-1.77M | ---- | -104.15%-9.84M |
Acquisition of subsidiaries | ---- | ---1.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 32.36%-255K |
Cash on investment | ---- | ---- | ---- | ---- | ---- | 81.63%-1.03M | ---- | 64.06%-5.61M | ---- | 0.00%-15.6M |
Other items in the investment business | 101.25%934K | ---- | -2,593.05%-74.94M | ---- | 495.01%3.01M | ---- | 39.17%-761K | ---- | 95.13%-1.25M | ---- |
Net cash from investment operations | 101.25%934K | -150.58%-1.72M | -2,593.05%-74.94M | 86.58%-688K | 495.01%3.01M | 41.16%-5.13M | 39.17%-761K | 66.08%-8.72M | 95.13%-1.25M | -23.55%-25.7M |
Net cash before financing | 109.15%10.9M | -122.02%-4.54M | -199.05%-119.13M | 208.49%20.62M | 116.69%120.28M | -3.29%-19.01M | -1,311.95%-720.53M | 82.46%-18.4M | 78.37%-51.03M | -207.71%-104.89M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -54.95%50M | ---- | -99.48%111M | ---- | 29.50%21.18B | ---- | 19,114.23%16.36B | ---- | 42.02%85.13M |
Refund | ---- | -78.76%-132.69M | ---- | 99.65%-74.23M | ---- | -29.06%-21.16B | ---- | -37,262.34%-16.4B | ---- | 48.40%-43.88M |
Issuing shares | ---- | --20.9M | ---- | ---- | ---- | --8.91M | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | -57.20%-11.46M | ---- | -1.83%-7.29M | ---- | 35.23%-7.16M | ---- | -66.66%-11.05M | ---- | -1.83%-6.63M |
Absorb investment income | ---- | -98.77%10K | ---- | --813K | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | 97.68%-19K | ---- | ---820K | ---- | ---- | ---- | ---2.48M | ---- | ---- |
Other items of the financing business | -186.30%-34.6M | ---- | 279.55%40.1M | ---- | -102.96%-22.33M | ---- | 6,839.78%754.49M | ---- | 699.01%10.87M | ---- |
Net cash from financing operations | -186.30%-34.6M | -576.03%-87.07M | 279.55%40.1M | 43.62%18.29M | -102.96%-22.33M | 120.95%12.74M | 6,839.78%754.49M | -478.53%-60.78M | 699.01%10.87M | 81.20%16.06M |
Effect of rate | ---- | -737.07%-1.94M | ---- | -123.39%-232K | ---- | 731.85%992K | ---- | -179.29%-157K | ---- | 386.96%198K |
Net Cash | 70.01%-23.7M | -335.44%-91.61M | -180.70%-79.04M | 720.46%38.91M | 188.42%97.95M | 92.08%-6.27M | 184.56%33.96M | 10.87%-79.18M | 83.11%-40.16M | -183.62%-88.84M |
Begining period cash | -37.72%154.44M | 18.48%247.99M | 17.44%247.99M | 0.22%209.31M | 1.10%211.16M | -27.53%208.86M | -27.53%208.86M | -23.52%288.19M | -23.52%288.19M | 39.23%376.83M |
Cash at the end | -22.62%130.74M | -37.72%154.44M | -45.34%168.95M | 21.82%247.99M | 27.30%309.11M | -2.53%203.58M | -2.10%242.82M | -27.53%208.86M | 78.36%248.03M | -23.52%288.19M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.